Αρχική World News Reflecting On My Time As the Cancer.Net Editor in Chief

Reflecting On My Time As the Cancer.Net Editor in Chief

It is with anticipatory nostalgia that I write my last blog as the Editor in Chief of Cancer.Net. It has been my privilege to work with an inspiring group of volunteers and staff over the past 6 years. Working together, we expanded the content and reach of Cancer.Net and adapted to face new health challenges by giving our readers important, timely information, including throughout the ongoing COVID-19 pandemic. Our experts on the Cancer.Net Editorial Board and the rest of the team at ASCO are committed to keeping the content fresh and evidence-based, and they recognize the power of sharing patient and survivor stories to help sustain and inspire those living with and beyond cancer.

Over the past several years, I have participated in several ASCO programs and have recorded podcasts and videos that still live on Cancer.Net. Our producer frequently commented during the recordings that I seemed very calm, even when discussing difficult topics. That’s because I learned from my patients that it is important to stay calm in order to understand the complexities that a life-changing illness and existential threat such as cancer can bring.

Having access to high-quality information can help people with cancer find their own sense of calm during the often-challenging time of a cancer diagnosis. It can also help them maintain that same sense of calm as they navigate the many stages of treatment and recovery. Cancer.Net was launched 19 years ago to make it easier to find high-quality information online from trusted voices. Since then, it has grown to include updates about the latest research, insightful patient and survivor stories, and useful resources delivered across many different media, including podcasts and videos.

Every Editor in Chief of Cancer.Net brings their own vision, and my vision is reflected in the expansion of content addressing supportive care, also called palliative care, for different populations living with and beyond cancer, as well as in the expanded translation of our content into Spanish and other languages. It is with great pride that I can say that Cancer.Net is now a trusted resource for more people across the globe whose lives are affected by cancer.

I am thrilled that Dr. Jyoti Patel will be taking over as Cancer.Net’s next Editor in Chief. She will bring her wisdom, enthusiasm, and creativity to the role. Jyoti knows the importance of providing a good dose of compassion mixed in with cancer treatment, and she remains unflappable despite her multiple roles as an academic leader, doctor, researcher, and mother.

It has been an honor to serve as the Cancer.Net Editor in Chief, and I look forward to celebrating more milestones and achievements of Cancer.Net under Jyoti’s leadership.

Source

Προηγούμενο άρθροReflections
Επόμενο άρθροCommon anti-inflammatory drug could boost cancer immunotherapy

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

10 Ways You Can Nurture A More Sustainable Garden

Sustainable gardening doesn’t have a firm, technical definition. It’s the concept of using sustainable gardening techniques that not only cause no harm to the...

Cancer Research UK spin-out gets US approval to trial unique T cell therapy

Cancer Research UK’s spin-out, GammaDelta Therapeutics (‘GammaDelta’), has been given approval from the US Food and Drug Administration (FDA) to trial its unique T-cell...

Platinum-Based Chemotherapy Versus Capecitabine in Patients With Residual TNBC Following Neoadjuvant Chemotherapy

The ECOG-ACRIN EA1131 study hypothesised that invasive disease-free survival (iDFS) would not be inferior but improved in patients with basal subtype triple-negative breast cancer...

Adding Checkpoint Inhibition to Anti-HER2 Breast Cancer Therapy Brings no Benefit [ESMO Virtual Plenary Press Release]

VP6-2021 - IMpassion050: A phase III study of neoadjuvant atezolizumab + pertuzumab + trastuzumab + chemotherapy (neoadj A + PH + CT) in high-risk,...

Breaking News: Supreme Court Upholds the Affordable Care Act

It’s a great day for cancer survivors. The Supreme Court of the United States (SCOTUS) upheld the Affordable Care Act (ACA), commonly known as...

How Does CAR T-Cell Therapy Work in Treating Cancer?

Craig A. Portell, MD, is an Associate Professor of Medicine at the University of Virginia and a member of the UVA Cancer Center in...